|
International News GlaxoSmithKline Spokesman Defends Company's Position on Patent Pools for HIV in Guardian Letter to the EditorSeptember 10, 2009 In a Guardian letter-to-the editor, Chris Strutt of GlaxoSmithKline responds to the newspaper's recent coverage of the GSK's position on a patent pool for HIV medicines. "Contrary to the impression given in your report ... GSK has been in discussions with UNITAID to better understand their objectives regarding an HIV patent pool," Strutt writes, adding, "We are in no way complacent about HIV ... Fighting this disease requires a multilateral approach and we are fully committed to playing our part" (Strutt, 9/10). Back to other news for September 2009
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report.
|
|